technetium-tc-99m-tetrofosmin and Meningioma

technetium-tc-99m-tetrofosmin has been researched along with Meningioma* in 5 studies

Other Studies

5 other study(ies) available for technetium-tc-99m-tetrofosmin and Meningioma

ArticleYear
Technetium Tc99m-tetrofosmin brain single-photon emission CT for the diagnosis of malignant meningiomas.
    AJNR. American journal of neuroradiology, 2009, Volume: 30, Issue:2

    Topics: Humans; Meningeal Neoplasms; Meningioma; Organophosphorus Compounds; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon

2009
Non-invasive assessment of meningioma Ki-67 proliferative index by 99mTc-Tetrofosmin brain scintigraphy.
    Neuropathology : official journal of the Japanese Society of Neuropathology, 2008, Volume: 28, Issue:1

    Topics: Humans; Ki-67 Antigen; Meningeal Neoplasms; Meningioma; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2008
(99m)Tc-Tetrofosmin SPECT for the assessment of meningioma malignancy.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2008, Volume: 15, Issue:6

    Topics: Brain; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Meningeal Neoplasms; Meningioma; Organophosphorus Compounds; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon

2008
Evaluation of meningioma aggressiveness by (99m)Tc-Tetrofosmin SPECT.
    Clinical neurology and neurosurgery, 2008, Volume: 110, Issue:7

    Although meningiomas usually have a benign clinical course, atypical and malignant types of this brain tumor are associated with high recurrence rates and poor outcome; thus, DNA ploidy and S-phase -- as determined by DNA flow cytometry -- are useful indicators of their biological behavior. Brain single-photon emission computed tomography (SPECT) has been suggested as a potentially useful modality for the metabolic assessment of various brain tumors. This study evaluated whether (99m)Tc-Tetrofosmin ((99m)Tc-TF) uptake correlates with meningioma proliferative activity, as assessed by flow cytometry analysis.. Ten consecutive patients (3 males, 7 females, mean age 64.6 years) with a diagnosis of a symptomatic intracranial meningioma, planned to undergo surgery, were studied. Brain SPECT by (99m)Tc-TF was performed within a week prior to surgical excision and flow cytometric analysis was performed in the excised tissue. Tumoral radiotracer accumulation was first assessed visually. Semiquantitative image analysis was also performed, by calculating the lesion-to-normal (L/N) uptake ratio.. Benign meningiomas were diagnosed in 8/10 cases, the remaining 2/10 patients had anaplastic lesions. DNA aneuploidy was found in 2 lesions, the remaining tumors were diploid. There was a significant correlation between tracer uptake and the percentage of the cell fraction on S-phase (r=0.733, P=0.05). There was also a positive correlation between tracer uptake and the level of aneuploidy and tumor grade.. These results imply that (99m)Tc-TF brain SPECT may have the ability to discriminate benign meningiomas from malignant meningiomas pre-operatively, the tracer uptake being a likely indicator of their proliferative activity.

    Topics: Aged; Cell Cycle; Female; Flow Cytometry; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meningioma; Middle Aged; Neoplasm Invasiveness; Organophosphorus Compounds; Organotechnetium Compounds; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

2008
Skull meningioma demonstrated with Tc-99m tetrofosmin SPECT.
    Clinical nuclear medicine, 1997, Volume: 22, Issue:9

    Topics: Female; Humans; Meningioma; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Parietal Bone; Radiopharmaceuticals; Skull Neoplasms; Tomography, Emission-Computed, Single-Photon

1997